ABSTRACT Isolated laryngeal histoplasmosis is a very rare entity. It has variable clinical presentations that might mimic both benign and malignant lesions, and is usually associated with pulmonary and other disseminated forms of histoplasmosis. Herein, we report a case of primary laryngeal histoplasmosis without the involvement of other systems in a 70-year-old Chinese man, who previously worked as a miner. He presented with a history of hoarseness for two months, with no other associated symptoms. Direct laryngoscopy revealed irregularity of the posterior onethird of both vocal folds. Histopathological examination revealed the presence of Histoplasma capsulatum on periodic acid-Schiff and Grocott's methenamine silver staining. The lesion resolved after one month of oral itraconazole treatment. However, the patient had to complete six months of antifungal treatment to prevent recurrence.
I NTRO D U C TIO N
Histoplasmosis is an infection caused by the intracellular fungus, Histoplasma capsulatum (H. capsulatum), and usually involves the respiratory system, particularly the lungs. H. capsulatum thrives well in damp acidic soil and spreads through inhalation of fungal spores, which travel into the lungs before entering the reticuloendothelial system. Isolated laryngeal histoplasmosis is therefore rare. Clinical presentations of laryngeal histoplasmosis may range from hoarseness and dysphagia to dyspnoea, with weight loss and malaise. (2) It may also present as leucoplakic lesions or exophytic masses.
(2)
CA S E R EPO RT
A 70-year-old Chinese man presented with a history of hoarseness for two months with no dyspnoea, dysphagia or odynophagia. He also had no constitutional symptoms or any history suggestive of tuberculosis infection.
Careful history taking revealed that the patient had been a heavy smoker for the past 50 years, and had been exposed to bird and bat droppings while working as a tin miner in the jungles for 30 years. Although he had retired ten years ago, he continued to go on regular hunting trips to the jungles after retirement. He had a history of diabetes mellitus (which was being treated with oral hypoglycaemic agents with good sugar control), rate-controlled atrial fibrillation and ischaemic heart disease.
Clinically, there was no respiratory distress, but the patient's voice was noted to be hoarse. There was no stridor, and neck and chest examinations were unremarkable. However, flexible nasopharyngolaryngoscopy showed that the mucosae at the posterior one-third of both vocal folds were irregular.
Screening for HIV was negative. While the patient's random blood glucose level was found to be mildly elevated, his renal profile was normal. As chest radiography showed a mild Intravenous (IV) amphotericin B was initiated at 0.5 mg/kg/day, and slowly tapered up. As the patient developed renal impairment after the second dose of IV amphotericin B, even though IV hydration was instituted prior to every dose of IV amphotericin B, a decision was made to withhold further treatment. Renal function improved after one week of hydration. However, serum creatinine remained mildly elevated. Therefore, the patient was given oral itraconazole 400 mg once daily.
On follow-up one month after the initiation of oral itraconazole therapy, the patient's voice had improved and 
D I SCU S S IO N
Histoplasmosis is caused by the inhalation of H. capsulatum spores. As it cannot be transmitted from human to human, it is not contagious. acquired immunodeficiency syndrome or malignancy, and patients on chemotherapy drugs, or high-dose or long-term steroid treatment), the infection will be disseminated to other systems. (5) Construction workers, (2) bridge inspectors or painters, (6) farmers, (7) as well as cave explorers (8) are at risk of being infected by H. capsulatum.
Histoplasmosis primarily involves the lungs, and isolated
histoplasmosis of the larynx is rare. To date, there are limited cases of primary laryngeal histoplasmosis reported in the literature compared to other laryngeal disorders. (9) In most of the reported cases, laryngeal histoplasmosis presented with various clinical symptoms including hoarseness, dysphagia, odynophagia, sore throat, dyspnoea, fatigue and weight loss. Involvement of the mucosa of other parts of the aerodigestive tract (13) and lungs should be excluded. Sputum must be sent for investigation and chest radiography must be done. The patient should also be screened for immunocompromised conditions such as HIV infection. If the patient is immunocompromised, more extensive examinations need to be performed to establish or obviate disseminated histoplasmosis.
IV amphotericin B is the mainstay of treatment for histoplasmosis and is effective in 68%-92% of patients. (14) The recommended dosage of IV amphotericin B for patients who require hospitalisation is 0.7-1.0 mg/kg/day, with the total dose to be administered over 2-4 months being 35mg/kg.
However, studies have shown that other oral antifungals are C a s e R e p o r t e210 as effective as IV amphotericin B in patients with mild to moderate histoplasmosis -oral itraconazole (200-400 mg once daily) was effective in treating 85%-100% of patients with disseminated histoplasmosis, (15) oral fluconazole (200-400 mg once daily) was effective in 86% of all patients, (15) while oral ketoconazole (200-400 mg once daily) was effective in 56%-70% of patients. (15) In summary, isolated laryngeal histoplasmosis is rare and might present with varied clinical presentations. For this reason, Histoplasma infection should be included in the differential diagnosis of miners and hunters presenting with laryngeal pathology. Biopsy specimens obtained during direct laryngoscopy should be sent for special staining and fungal culture. Besides IV amphotericin B, it is possible to use oral antifungals to treat isolated laryngeal histoplasmosis.
